Organogenesis Holdings (ORGO) Total Debt Growth (1y) (2018 - 2024)
Organogenesis Holdings (ORGO) Total Debt Growth (1y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 41.53% |
| 10 | Organogenesis Holdings | 241.78 Mn | 194.94 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -8.11% |
| Jun 30, 2024 | -7.95% |
| Mar 31, 2024 | -7.17% |
| Dec 31, 2023 | -6.41% |
| Sep 30, 2023 | -6.89% |
| Jun 30, 2023 | -4.96% |
| Mar 31, 2023 | -4.28% |
| Dec 31, 2022 | -3.62% |
| Sep 30, 2022 | -5.36% |
| Jun 30, 2022 | -21.55% |
| Mar 31, 2022 | 22.17% |
| Dec 31, 2021 | 22.97% |
| Sep 30, 2021 | 50.37% |
| Jun 30, 2021 | 101.00% |
| Mar 31, 2021 | 412.14% |
| Dec 31, 2020 | 55.16% |
| Sep 30, 2020 | 240.13% |
| Jun 30, 2020 | 2.27% |
| Mar 31, 2020 | -74.07% |
| Dec 31, 2019 | 84.27% |